Skip to main content
Log in

Syndrome of inappropriate secretion of antidiuretic hormone caused by vincristine therapy: a case report of the neuropathology

  • Short Communications
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Summary

The syndrome of inappropriate secretion of antidiuretic hormone is a rare but well-recognized neurotoxic side effect of vincristine therapy. The first neuropathological report of a case is presented. A 6-month-old boy with skin leukemia developed inappropriate secretion of antidiuretic hormone caused by vincristine. Postmortem examination revealed axonal spheroids in the ansa lenticularis and the area surrounded by the substantia innominata, amygdala and supraoptic nucleus. The lesion was confined to that area and the neurosecretory neurons were intact with well preserved neurophysin. The pathological findings suggest that these fibers play a role in the development of inappropriate secretion of antidiuretic hormone caused by vincristine therapy.

Zusammenfassung

Das Syndrome der ungenügenden Sekretion des antidiuretischen Hormones ist eine zwar bereits beschriebene, aber seltene Nebenwirkung einer Vincristine-Therapie. Es wird der erste neuropathologisch untersuchte Fall vorgestellt. Bei einem sechs Monate alten Knaben mit einer Leukämie der Haut trat nach Vincristine-Therapie eine Störung der Sekretion des antidiuretischen Hormons auf. Die histologische Untersuchung ergab spheroide Veränderungen der Axone im Bereiche der Ansa lenticularis und im Bereiche der Substantia innominata, der Amygdala und des Nucleus supraopticus. Die Veränderungen beschränkten sich auf die erwähnten Bezirke, während die neurosekretorischen Neurone unauffällig erschienen mit gut erhaltenem Neurophysin. Die neuropathologischen Befunde legen die Annahme nahe, daß die erwähnten Fasern eine Rolle bei der Entstehung der Störung der Sekretion des antidiuretischen Hormons bei Vincristine-Therapie spielen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Cross BA, Dyball REJ (1974) Ventral pathways for neurohypophyseal hormone release. In: Knoball E, Sawyer WH (eds) Handbook of physiology, vol 4. Williams and Wilkins, Baltimore, pp 269–285

    Google Scholar 

  2. Cutting HO (1971) Inappropriate secretion of antidiuretic hormone secondary to vincristine therapy. Am J Med 51:269–271

    Google Scholar 

  3. Goldberg M (1963) Hyponatremia and the inappropriate secretion of antidiuretic hormone. Am J Med 35:293–298

    Google Scholar 

  4. Green LS, Donoso A, Heller-Bettinger IE, Samson FE (1977) Axonal transport disturbances in vincristine-induced peripheral neuropathy. Ann Neurol 1:255–262

    Google Scholar 

  5. Jellinger K (1973) Neuroaxonal dystrophy: its natural history and related disorders. In: Zimmerman HM (ed) Progress in neuropathology, vol 2. Grune and Stratton, New York London, pp 129–180

    Google Scholar 

  6. Liu HM (1978) Reactive neuroaxonal dystrophy in children. Acta Neuropathol 42:237–241

    Google Scholar 

  7. Mattler FA (1968) Anatomy of the basal ganglia. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology, vol 16. Elsevier, Amsterdam, pp 1–55

    Google Scholar 

  8. Plum F, Uiter RV (1978) Nonendocrine disease and disorders of the hypothalamus. In: Reichin S, Baldessarini RJ, Martin RJ (eds) The hypothalamus. Raven Press, New York, pp 415–473

    Google Scholar 

  9. Rosenthal S, Kaufman S (1974) Vincristine neurotoxicity. Ann Intern Med 80:733–737

    Google Scholar 

  10. Roussy G, Mosinger M (1934) La substance innominée de Reichert et ses connection. Rev Neurol (Paris) 41:873–875

    Google Scholar 

  11. Schochet SS, Lampert PW, Karle KM (1968) Neuronal change induced by intrathecal vincristine sulfate. J Neuropathol Exp Neurol 27:645–656

    Google Scholar 

  12. Schwartz WB, Bennett W, Curelop S, Barlter FC (1957) A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med 23:529–542

    Google Scholar 

  13. Shelenski ML, Wisniewski H (1969) Neurofibrillary degeneration. Arch Neurol 20:199–206

    Google Scholar 

  14. Slyter H, Liwnicz B, Herrick MK, Mason R (1980) Fatal myeloencephalopathy caused by intrathecal vincristine. Neurology (Minneap) 30:867–871

    Google Scholar 

  15. Sung JH, Mastri AR, Park SH (1981) Axonal dystrophy in the gracile nucleus in children and young adults. J Neuropathol Exp Neurol 40:37–45

    Google Scholar 

  16. Tomiwa K, Hazama F, Mikawa H (1983) Neurotoxicity of vincristine after osmotic opening of the blood-brain barrier. Neuropathol Appl Neurobiol (in press)

  17. Young DF, Ponsner JB (1980) Nervous toxicity of the chemotherapeutic agents. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology, vol 39. Elsevier, Amsterdam, pp 91–129

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tomiwa, K., Mikawa, H., Hazama, F. et al. Syndrome of inappropriate secretion of antidiuretic hormone caused by vincristine therapy: a case report of the neuropathology. J Neurol 229, 267–272 (1983). https://doi.org/10.1007/BF00313556

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00313556

Key words

Navigation